Recordati Industria Chimica e Farmaceutica S.p.A.
RCDTF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $2 | $2 | $2 | $2 |
| % Growth | 12.4% | 12.4% | 17.3% | – |
| Cost of Goods Sold | $1 | $1 | $1 | $0 |
| Gross Profit | $2 | $1 | $1 | $1 |
| % Margin | 68.3% | 71.1% | 69.4% | 72.9% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $1 | $1 | $1 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | -$0 |
| Operating Expenses | $1 | $1 | $1 | $1 |
| Operating Income | $1 | $1 | $0 | $0 |
| % Margin | 27.3% | 26.8% | 23.6% | 31% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | $1 | $0 | $0 | $0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 17.8% | 18.7% | 16.9% | 24.4% |
| EPS | 2.02 | 1.86 | 1.52 | 1.87 |
| % Growth | 8.6% | 22.4% | -18.7% | – |
| EPS Diluted | 1.99 | 1.86 | 1.49 | 1.85 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $1 | $1 | $1 | $1 |
| % Margin | 34% | 34% | 30.2% | 36.6% |